FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/24/2026
Back to search
Official data from USPTO
IMMUNE ONCIA THERAPEUTICS INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
06/24/2026
Trademark type
Combined
Nice classes
42
Filing date
12/31/2024
Registration date
03/24/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2026
Last transaction
06/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
KR
Examiner
STRUCK, ROBERT J
Law office
L90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "IMMUNEONCIA THERAPEUTICS INC." with "IMMUNE" and "IA " in black, "ONC in blue and "THERAPEUTICS INC." in gray and a design of various circles in blue and sky-blue with one circle connecting to the "O" forming an amoeba-like shape.
Holders and representatives
Holders
ImmuneOncia Therapeutics, Inc.
Representatives
Dmitriy O. Makarov IpHorgan Ltd.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; medical research laboratory services; providing information on the testinginspection and research of medical products; pharmaceutical product evaluation; engineering services in the medical technology; medical research; drug discovery services; research and development of new products for others; chemical laboratory services; biotechnology research; technical consultancy in relation to research services relating to foods and dietary supplements
Publications
History of USPTO decisions and trademark events.
22 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/24/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/03/2026
PUBO
PUBLISHED FOR OPPOSITION
02/03/2026
GPNX
NOTIFICATION PROCESSED BY IB
01/29/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/28/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/14/2026
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/13/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2025
RFNT
REFUSAL PROCESSED BY IB
08/23/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/06/2025
RFRR
REFUSAL PROCESSED BY MPU
08/06/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/18/2025
CNRT
NON-FINAL ACTION WRITTEN
06/17/2025
DOCK
ASSIGNED TO EXAMINER
06/12/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/28/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/28/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/24/2025
Continuous trademark protection
Get notified about every new filing that threatens IMMUNE ONCIA THERAPEUTICS INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.